Biocon share price rose 4.5% following US FDA clearance for its Malaysian insulin facility, resolving a regulatory bottleneck. Bank of America raised its price target by 9% to ₹435, reflecting ...
The FDA just announced changes to help make berries sold in the U.S. safer to eat, lowering the odds you’ll get norovirus or ...
The global craze over Ozempic as a weight-loss solution has hit Malaysia, with pharmacies experiencing a surge in demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback